Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon therapy in chronic active viral hepatitis]

G Lengyel1, J Fehér

  • 1II. Belklinika, Semmelweis Orvostudományi Egyetem, Budapest.

Orvosi Hetilap
|January 1, 1995
PubMed
Summary

Interferon therapy offers significant progress for chronic viral hepatitis B, C, and D. While not a cure for all, combination therapies show promise for improved patient recovery outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eye on the Gut: Irritable Eye Syndrome

La Clinica terapeutica·2019
Same author

Screening of more than 2000 Hungarian healthcare workers' anti-measles antibody level: results and possible population-level consequences.

Epidemiology and infection·2018
Same author

Occlusion of retinal capillaries caused by glial cell proliferation in chronic ocular inflammation.

Folia morphologica·2015
Same author

The Use of the S-MART Tourniquet in Hand Surgery: A Safe and Effective Way to Provide a Bloodless Field.

Surgery research and practice·2014
Same author

Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort.

Journal of viral hepatitis·2013
Same author

Increased total scavenger capacity in rats fed corticosterone and cortisol on lipid-rich diet.

Acta physiologica Hungarica·2012

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Context:

  • Chronic viral hepatitis B, C, and D pose significant global health challenges.
  • Current therapeutic strategies for viral hepatitis require ongoing evaluation and improvement.
  • Interferon-based treatments have been a cornerstone in managing these conditions.

Purpose:

  • To review recent data on interferon types and their biological activities.
  • To discuss the efficacy of interferons in treating chronic viral hepatitis B, C, and D.
  • To explore the potential of combination therapies for enhanced treatment outcomes.

Summary:

  • Interferon therapy represents a substantial advancement in managing chronic viral hepatitis.
  • Treatment success rates for chronic hepatitis B range from 25-40%, and for hepatitis C, 40-45%.
  • Combination therapy approaches are highlighted as a promising future direction for viral hepatitis treatment.

Impact:

  • Provides an overview of interferon's role and limitations in viral hepatitis management.
  • Highlights the need for further research into more effective treatment modalities.
  • Suggests combination therapies as a key area for future clinical development and improved patient prognoses.

Related Experiment Videos